Home
Conditions
Female Urogenital Diseases

Clinical trial condition

Female Urogenital Diseases

Explore clinical trials studying Female Urogenital Diseases. Study availability and eligibility vary by location and protocol.

22,021 public trials 3,763 recruiting studies

Refine in advanced search Browse all conditions

Female Urogenital Diseases trial results

Recruiting

Personalized Rituximab Treatment Based on Artificial Intelligence in Membranous Nephropathy (iRITUX)

NCT06341205

Conditions: Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: CHU de BESANCON Besançon, France

CHU de BORDEAUX - Hôpital Pellegrin Bordeaux, France

CHU de CAEN Caen, France

AP-HP - Hôpital H. Mondor Créteil, France

View all 14 locations

View Trial Details

Recruiting

RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer

NCT03675893

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations: Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Recruiting

Prognostic Role of Inhibitor of Apoptosis Protein Overexpression on Recurrence Rate in Cervical Cancer

NCT06147960

Conditions: Apoptosis, Cancer of Cervix, Female Urogenital Diseases, +12 more
Locations: CHU de Nîmes Nîmes, Gard, France

View Trial Details

Recruiting

A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device

NCT05922657

Conditions: Abnormal Uterine Bleeding, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations: Axia Women's Health / Rubino OB/GYN Group West Orange, New Jersey, United States

Seven Hills Women's Health Centers Cincinnati, Ohio, United States

View Trial Details

Recruiting

Individualised Endometrial Cancer Risk Stratification by Bayesian Prediction Model (ENDORISK), Optimizing Clinical Implementation

NCT07200466

Conditions: Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +15 more
Locations: Rijnstate Arnhem, Gelderland, Netherlands

Slingeland Hospital Doetinchem, Gelderland, Netherlands

Gelderse Vallei Ede, Gelderland, Netherlands

Radboudumc Nijmegen, Gelderland, Netherlands

View all 14 locations

View Trial Details

Recruiting

STarting incrEmental Prescription of Peritoneal Dialysis

NCT06642597

Conditions: Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Kidney Diseases, +6 more
Locations: Blacktown Blacktown, New South Wales, Australia

Princess Alexandra Hospital Brisbane, Queensland, Australia

Eastern Health Box Hill, Victoria, Australia

Waitemata Auckland, New Zealand

View Trial Details

Recruiting

Comparison of Immediate Changes in Cervical Range of Motion Following Cervical Extension and Downslip Mobilizations.

NCT07656285

Conditions: Cervical Disease, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +5 more
Locations: Missouri State University - Physical Therapy Clinic Springfield, Missouri, United States

View Trial Details

Recruiting

An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Safe it is and How Well it Works Under Real-world Conditions

NCT06278207

Conditions: Chronic Disease, Chronic Kidney Disease, Diabetes Mellitus, +17 more
Locations: Many Locations Multiple Locations, New Jersey, United States

Bayer Berlin, Germany

Many Locations Multiple Locations, Japan

Many Locations Multiple Locations, Taiwan

View Trial Details

Recruiting

A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

NCT07503808

Conditions: Breast Diseases, Breast Neoplasms, Bronchial Neoplasms, +48 more
Locations: Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States

Florida Cancer Specialists Sarasota, Florida, United States

Karmanos Cancer Institute Detroit, Michigan, United States

START New York Long Island, LLC Lake Success, New York, United States

View all 15 locations

View Trial Details

Recruiting

ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer

NCT05071937

Conditions: Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations: University of Pittsburgh Medical Center Pittsburgh, Pennsylvania, United States

View Trial Details

Female Urogenital Diseases

Female Urogenital Diseases trial results

Related conditions